| Net Cash Provided by (Used in) Operating Activities |
-405M |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
449M |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
58.2M |
shares |
+834% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
43.6M |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
217M |
USD |
+1364% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
5.69M |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
0 |
USD |
-100% |
Q3 2025 |
Q3 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
7.23M |
USD |
+4955% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
2.82M |
USD |
+28130% |
Q3 2025 |
Q3 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
-8.51M |
USD |
|
Q3 2025 |
Q3 2025 |
| Current Income Tax Expense (Benefit) |
0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
1.38B |
USD |
+789% |
Q3 2025 |
Q3 2025 |
| Current State and Local Tax Expense (Benefit) |
0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
7.23M |
USD |
+22491% |
Q3 2025 |
Q3 2025 |
| Deferred State and Local Income Tax Expense (Benefit) |
-827K |
USD |
|
Q3 2025 |
Q3 2025 |
| Interest Expense |
7.87M |
USD |
+938% |
Q3 2025 |
Q3 2025 |